中西医结合治疗非酒精性脂肪肝163例

来源 :中国医疗前沿 | 被引量 : 0次 | 上传用户:lowner
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的探讨非酒精性脂肪肝的中西医结合治疗方法及疗效。方法回顾性分析我院2010年1月-2012年4月收治的163例非酒精性单纯性脂肪肝患者,按随机数字表法分为对照组80例给予西医常规疗法,观察组83例在对照组基础上给予中药降脂汤。比较两组临床总有效率,以及肝功能变化[门冬氨酸氨基转移酶(AST)、血清谷丙转氨酶(ALT)、白蛋白(ALB)、凝血酶原活动度(PTA)]。结果观察组总有效率94.0%,高于对照组的82.2%(P<0.05),观察组的AST、ALT、ALB、PTA指标好于对照组(P<0.05,P<0.01)。结论中西医结合治疗非酒精性脂肪肝,疗效确切,有效改善患者肝功能,值得临床推广应用。 Objective To explore the treatment of non-alcoholic fatty liver with integrated traditional Chinese and western medicine and its curative effect. Methods A retrospective analysis of 163 patients with non-alcoholic simple fatty liver treated in our hospital from January 2010 to April 2012 was divided into control group (n = 80) and conventional therapy (n = 83) by observation group (n = 83) Based on the group given Chinese lipid-lowering soup. The total effective rate of the two groups was compared, as well as changes of liver function (AST, ALT, ALB, PTA). Results The total effective rate in observation group was 94.0%, which was higher than that in control group (82.2%, P <0.05). The indexes of AST, ALT, ALB and PTA in observation group were better than those in control group (P <0.05, P <0.01). Conclusion Integrative treatment of non-alcoholic fatty liver, curative effect is exact, effective in improving liver function, it is worthy of clinical promotion and application.
其他文献
目的探讨介入治疗动脉导管未闭伴肺动脉高压患儿疗效。方法选择我院2009年12月-2011年12月动脉导管未闭合并肺动脉高压患儿32例,同时排除介入治疗的手术禁忌症患儿。肺动脉小
在信息技术与互联网技术已经普及应用到生产生活的现代化社会,马克思主义的大众化传播工作已经离不开网络媒体.网络媒体作为一种主流技术对于推动马克思主义中国化有着十分关
期刊
目的探讨微生物制剂金双歧治疗肝硬化腹泻的疗效.方法选取68例肝硬化腹泻患者,随机分为治疗组及对照组各34例,治疗组常规保肝支持治疗加金双歧(4粒/次,2次/d);对照组常规保肝